Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vink

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Molecular Diagnostics : JMD|September 22, 2020
Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal CancerIris van 't Erve, Marjolein J E Greuter, Karen Bolhuis, et al.
Therapeutic Advances in Medical Oncology|November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectivenessHaoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
Life Science Alliance|May 23, 2024
A consensus molecular subtypes classification strategy for clinical colorectal cancer tissuesTim R de Back, Tan Wu, Pascale Jm Schafrat, et al.
Life Science Alliance|June 27, 2024
Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissuesTim R de Back, Tan Wu, Pascale Jm Schafrat, et al.
ESMO Open|January 3, 2026
Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapyI A Franken, F Heilijgers, M-C E Bakker, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 8, 2024
Development of a prediction model for clinically-relevant fatigue: a multi-cancer approachDhirendra Adiprakoso, Dimitris Katsimpokis, Simone Oerlemans, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer|August 8, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancerSimone van de Weerd, Arezo Torang, Inge van den Berg, et al.
Applied Optics|September 11, 2019
International round-robin experiment for angle-resolved light scattering measurementA von Finck, T Herffurth, A Duparré, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Molecular Diagnostics : JMD|September 22, 2020
Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal CancerIris van 't Erve, Marjolein J E Greuter, Karen Bolhuis, et al.
Therapeutic Advances in Medical Oncology|November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectivenessHaoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
Life Science Alliance|May 23, 2024
A consensus molecular subtypes classification strategy for clinical colorectal cancer tissuesTim R de Back, Tan Wu, Pascale Jm Schafrat, et al.
Life Science Alliance|June 27, 2024
Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissuesTim R de Back, Tan Wu, Pascale Jm Schafrat, et al.
ESMO Open|January 3, 2026
Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapyI A Franken, F Heilijgers, M-C E Bakker, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 8, 2024
Development of a prediction model for clinically-relevant fatigue: a multi-cancer approachDhirendra Adiprakoso, Dimitris Katsimpokis, Simone Oerlemans, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
International Journal of Cancer|August 8, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancerSimone van de Weerd, Arezo Torang, Inge van den Berg, et al.
Applied Optics|September 11, 2019
International round-robin experiment for angle-resolved light scattering measurementA von Finck, T Herffurth, A Duparré, et al.
Pageof 21